Search Results - "Heynen, G."

Refine Results
  1. 1
  2. 2
  3. 3

    PO-201 Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase by Ruess, D, Heynen, G, Ciecielski, K, Birchmeier, W, Schmid, R, Algül, H

    Published in ESMO open (01-07-2018)
    “…IntroductionThe ubiquitously expressed non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, is involved in signal transduction downstream of…”
    Get full text
    Journal Article
  4. 4

    Lack of effect of long-term amlodipine on insulin sensitivity and plasma insulin in obese patients with essential hypertension by DE COURTEN, M, FERRARI, P, SCHNEIDER, M, BÖHLEN, L, SHAW, S, RIESEN, W, HEYNEN, G, WEIDMANN, P

    Published in European journal of clinical pharmacology (01-06-1993)
    “…To evaluate the effects of long-term treatment antihypertensive with the dihydropyridine calcium antagonist amlodipine on insulin sensitivity, plasma insulin,…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Unaltered insulin sensitivity during calcium channel blockade with amlodipine by FERRARI, P, GIACHINO, D, WEIDMANN, P, SHAW, S, RIESEN, W, NEUNER, N, KELLER, U, HEYNEN, G

    Published in European journal of clinical pharmacology (01-01-1991)
    “…The sensitivity of peripheral tissues to insulin is of pathophysiological, therapeutic and possibly also of prognostic relevance. Calcium channel blockers are…”
    Get full text
    Journal Article
  7. 7

    Proteoglycan metabolism in tissue cultured human articular cartilage. Influence of piroxicam by Verbruggen, G, Veys, E M, Malfait, A M, Cochez, P, Schatteman, L, Wieme, N, Heynen, G, Broddelez, C

    Published in Journal of rheumatology (01-03-1989)
    “…Proteoglycan metabolism was investigated in longterm tissue cultured human cartilage. Visually intact cartilage from adult donors showed improving accumulation…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Piroxicam suppositories for osteoarthritis and rheumatoid arthritis: an open multicentre study in 116 patients by Heynen, G, Dessain, P

    “…Efficacy and toleration of piroxicam suppositories 20 mg, given once daily for 4 weeks were assessed in 96 patients suffering from degenerative joint disease…”
    Get more information
    Journal Article
  12. 12

    Proteoglycan metabolism in isolated chondrocytes from human cartilage and in short-term tissue-cultured human articular cartilage by Verbruggen, G, Veys, E M, Malfait, A M, Schatteman, L, Wieme, N, Heynen, G, Vanhoutte, V, Broddelez, C

    Published in Clinical and experimental rheumatology (01-01-1989)
    “…The effect of piroxicam on proteoglycan metabolism of human cartilage cells was investigated in two in vitro models. Cells or tissue samples were obtained from…”
    Get more information
    Journal Article
  13. 13

    Evidence that endogenous calcitonin protects against renal bone disease by Kanis, J A, Oliver, D, Ledingham, J C, Russell, R G

    Published in The Lancet (British edition) (01-01-1976)
    “…Plasma concentrations of calcium, phosphate, alkaline phosphatase (A.P.), immunoreactive calcitonin (iC.T.), and immunoreactive parathyroid hormone (iP.T.H.)…”
    Get more information
    Journal Article
  14. 14

    Suppressive effects of 24,25-dihydroxycholecalciferol on bone resorption induced by acute bilateral nephrectomy in rats by Pavlovitch, J H, Cournot-Witmer, G, Bourdeau, A, Balsan, S, Fischer, J A, Heynen, G

    Published in The Journal of clinical investigation (01-09-1981)
    “…The possible suppressive effects of 24,25-dihydroxycholecalciferol on secondary hyperparathyroidism and increased bone resorption were investigated in adult…”
    Get full text
    Journal Article
  15. 15

    Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent by Ferrari, P, Weidmann, P, Shaw, S, Giachino, D, Riesen, W, Allemann, Y, Heynen, G

    Published in The American journal of medicine (01-12-1991)
    “…Essential hypertension is, in some patients, complicated by impairment of insulin-mediated glucose disposal and hyperinsulinemia. Whether this metabolic…”
    Get more information
    Journal Article
  16. 16

    An estimate of the endogenous secretion rate of calcitonin in man by Kanis, J A, Heynen, G, Cundy, T, Cornet, F, Paterson, A, Russell, R G

    Published in Clinical science (1979) (01-08-1982)
    “…1. The metabolic clearance rate (MCR) of human calcitonin was measured in 12 normal subjects and four patients with Paget's disease by the infusion of…”
    Get more information
    Journal Article
  17. 17

    Vitamin A and hyperparathyroid bone disease in uremia by Cundy, T, Earnshaw, M, Heynen, G, Kanis, JA

    Published in The American journal of clinical nutrition (01-01-1983)
    “…The possible contribution of hypervitaminosis A to bone disease in uremia was examined in 50 dialysis-treated patients with end-stage chronic renal failure…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man? by Kanis, J A, Cundy, T, Bartlett, M, Smith, R, Heynen, G, Warner, G T, Russell, R G

    Published in British Medical Journal (27-05-1978)
    “…Small doses (1-10 microgram daily) of 24,25-dihydroxycholecalciferol (24,25-(OH)2D3), a renal metabolite of vitamin D of uncertain function, increased…”
    Get full text
    Journal Article
  20. 20

    Double-blind placebo-controlled evaluation of levamisole in chronic rheumatoid arthritis by Franchimont, P, Heynen, G, Berghs, H, Remans, J, Vroninks, P

    “…Thirty-three out-patients with rheumatoid arthritis completed the study intended to compare under double-blind conditions, 50 mg levamisole tablets with…”
    Get more information
    Journal Article